19 May 2013
Keywords: fujisawa, drug, clears, phase, ii, af, japan
Article | 31 March 2003
Japan's Fujisawa has paid Aderis Pharmaceuticals of the USA a $2 millionmilestone in connection with the final completion of a Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 March 2003
17 May 2013
© 2013 thepharmaletter.com